Cases 1 - 10 of 31
Keryx Biopharmaceuticals, Inc. et al v. Zydus Worldwide DMCC et al
as 1:2023cv00331
Plaintiff:
Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc.
Defendant:
Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Keryx Biopharmaceutical
as 21-1870
Defendant / Appellee:
KERYX BIOPHARMACEUTICALS INC, JODIE MORRISON, DANIEL P. REGAN and others
Plaintiff / Appellant:
ABRAHAM KISWANI and JOHN ANDREULA, Individually and on Behalf of All Other Similarly Situated
In re: Keryx Biopharmaceutical
as 20-2019
Defendant / Appellee:
KERYX BIOPHARMACEUTICALS INC, MICHAEL ROGERS, JODIE MORRISON and others
Plaintiff / Appellant:
ABRAHAM KISWANI and JOHN ANDREULA
Karth v. Keryx Biopharmaceuticals, Inc., et al
as 19-1964
Defendant / Appellee:
KERYX BIOPHARMACEUTICALS, INC., GREGORY P. MADISON, JAMES OLIVIERO and others
Plaintiff:
RICHARD J. ERICKSON, ABRAHAM KISWANI, JACKSON TERRELL, Individually and on behalf of all others similarly situated and others
Plaintiff / Appellant:
TIM KARTH
Interested Party:
MARNA IZZO and MIKE IZZO
Keryx Biopharmaceuticals, Inc et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv01445
Plaintiff:
Panion & BF Biotech, Inc., Keryx Biopharmaceuticals, Inc. and Chen Hsing Hsu
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Auryxia (Ferric Citrate) Patent Litigation
as 1:2019md02896
Not Classified By Court:
Chemo Research S.L., Insud Pharma S.L., Teva Pharmaceuticals USA, Inc. and others
Counter Defendant:
Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc. and Chen Hsing Hsu
Counter Claimant:
Lupin Atlantis Holdings SA and Lupin Ltd.
In Re:
In re: Auryxia (Ferric Citrate) Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Keryx Biopharmaceuticals, Inc. et al v. PAR Pharmaceutical, Inc.
as 1:2019cv04876
Plaintiff:
Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc.
Defendant:
PAR Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Keryx Biopharmaceuticals, Inc. et al v. Par Pharmaceutical, Inc.
as 1:2019cv00955
Plaintiff:
Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc.
Defendant:
Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Keryx Biopharmaceuticals, Inc. et al v. Watson Laboratories, Inc. et al
as 2:2019cv00837
Plaintiff:
Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc.
Defendant:
Watson Laboratories, Inc., Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 145
Keryx Biopharmaceuticals, Inc. et al v. Lupin Ltd.
as 1:2019cv00884
Plaintiff:
Keryx Biopharmaceuticals, Inc., Chen Hsing Hsu and Panion & BF Biotech, Inc.
Defendant:
Lupin Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
